Skip to main content
. 2019 Mar 4;2(2):45–53. doi: 10.1093/abt/tbz004

Figure 5.

Figure 5

Head-to-head comparison of GSK-Cervarix vs YCL-HPV16/18. The blue line (YCL-01 and YCL02) indicated the animal number receiving our YCL-HPV16/18 L1-L2 VLPs immunization; the pink line (GSK-01 and GSK-02) indicated the animal number receiving the immunization of the Cervarix of GSK. (A) The schedule of immunization; the characterization of the second anti-sera against HPV16 L1 (B) and HPV18 L1 (C), respectively; the characterization of the third anti-sera against HPV16 L1 (D) and HPV18 L1 (E), respectively. Data represent mean ± SD; two-tailed, unpaired, Student’s t-tests were performed. **P < 0.01.